Prevention of Defects of Axonal Transport in Experimental Diabetes by Aldose Reductase Inhibitors
- 1 January 1986
- journal article
- Published by Springer Nature in Drugs
- Vol. 32 (2) , 15-18
- https://doi.org/10.2165/00003495-198600322-00005
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prevention and Reversal of Defective Axonal Transport and Motor Nerve Conduction Velocity In Rats with Experimental Diabetes by Treatment with the Aldose Reductase Inhibitor SorbinilDiabetes, 1984
- DEFECTS OF AXONAL TRANSPORT IN DIABETES MELLITUS — A POSSIBLE CONTRIBUTION TO THE AETIOLOGY OF DIABETIC NEUROPATHYJournal of Autonomic Pharmacology, 1984
- Polyol Pathway Activity and Myo-Inositol Metabolism: A Suggested Relationship in the Pathogenesis of Diabetic NeuropathyDiabetes, 1983
- Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic ratsDiabetologia, 1983
- Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibitionDiabetologia, 1983
- Diabetic Neuropathy—New Concepts of Its EtiologyDiabetes, 1979
- Peripheral nerves in early experimental diabetesDiabetologia, 1978
- Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.Journal of Clinical Investigation, 1975
- The Sorbitol Pathway and the Complications of DiabetesNew England Journal of Medicine, 1973
- Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in DiabetesScience, 1966